ARTRITA, TRATEAZ O PE CALE NATURALA !!!

contact
Categorii
Marci

ARTRITA, TRATEAZ O PE CALE NATURALA !!!

RON
Cumpara produs
Stoc: Indisponibil
MEDACTIV MEDFARMA
Specificatii ARTRITA, TRATEAZ O PE CALE NATURALA !!!
  • Marca: MEDACTIV MEDFARMA
  • Rating: [0] voturi
Alte detalii

-ARTRITA, Trateaz-o pe cale naturala

-Cai naturale de usurare a durerii provocate de artrita
(W. Gifford-Jones, M.D.
16.08.2006
Epoch Times)

-ARTRITA:
-Tratamentele naturale sunt mai sigure si pot fi mai eficiente decat terapia prin medicamente. (Christopher Furlong/Getty Images)
“De ce luati medicamente cand nici nu ati incercat caile naturale de usurare a durerii provocate de artrita?” Deseori intreb pacientii acest lucru. Le aduc aminte ca ei nu inghit bomboane M&M ci medicamente puternice care pot cauza complicatii majore. Mai mult, ei uita ca multe substante naturale pot fi folosite nu doar la vindecare ci si la prevenirea osteoartritei care vine o data cu imbatranirea.

-Vitamina C este cel mai analizat remediu natural

-Osteoartrita este indeosebi o deteriorare a cartilagiului si cand acesta este diminuat pe masura ce imbatranesti, oasele se freaca unele de altele cauzand durere

-Secretul este de a mentine cartilagiul sanatos !!!

-O prima cale este folosirea unei cantitati potrivite de vitamina C, care este necesara pentru crearea de colagen, un ingredient important al cartilagiului.

-Cercetatorii de la Centrul Medical al Universitatii din Boston au studiat consumul de vitamina C la 640 de oameni. Ei au descoperit ca cei cu un consum mai ridicat de vitamina C au fost protejati impotriva avansarii osteoartritei la genunchi. A incetinit de asemenea dezvoltarea durerii la genunchi.

-De cata vitamina C este nevoie? Linus Pauling, de doua ori castigator al Premiului Nobel a raportat ca, spre deosebire de animale, oamenii nu produc vitamina C. Cei mai multi oameni sunt, prin urmare, deficitari in aceasta vitamina. Pauling a luat 20 de miligrame (mg) zilnic. Doza zilnica recomandata este de 75 mg. Daca decizi sa iei mai mult decat cantitatea recomandata a acestei vitamine, discuta aceasta problema cu doctorul tau. Cantitatile mari pot cauza diaree si crampe abdominale.

-Daca nu iti folosesti articulatiile le vei pierde !!!

-Exercitiile pompeaza mecanismul care impinge elementele nutritive in articulatii, oferind mijloacele de hranire a cartilagiului

-Sunt convins ca consumul scazut, lipsa consumului impreuna cu cantitatile inadecvate de vitamina C, sunt principalele motive pentru care atat de multi oameni au nevoie de modificari la solduri si genunchi.

-Sulfatul (Clorhidratul) de glucozamina sau sulfatul de condroitin ajuta la usurarea durerii? Aceasta ramane inca o intrebare fara raspuns. Dar aceste suplimente au fost folosite multi ani in Europa pentru a preveni si trata artrita. Glucozamina da cartilagiului structura sa. Condroitinul lucreaza impreuna cu glucozamina pentru a atrage si pastra apa, oferind cartilagiului efectul sau de amortizare. Asa ca sa fiti siguri ca veti consuma zilnic fie cateva pahare de apa fie alte lichide pentru a mentine cartilagiul genunchiului bine hidratat.

-Cateva rapoarte arata ca pacientii care i-au 15 mg de glucozamina si 12 mg de condroitin zilnic cu mesele lor au mai putine dureri si o mobilitate crescuta, comparativ cu cei care au fost tratati cu placebo. Un studiu belgian a aratat de asemenea ca pierderea de cartilagiu fie a incetit fie s-a oprit cand pacientii au luat aceste suplimente. Dar alte rapoarte sunt mai putin entuziasmate de folosirea acestor suplimente, sustinand ca ofera doar putin ajutor sau nu ajuta deloc.

-Din moment ce glucozamina este facuta din carcasa de crustaceu, oamenii cu alergie la crustacei ar trebui sa evite consumului ei. Cei cu diabet ar trebui sa verifice nivelul zaharului din sangele lor, deoarece studiile pe animale arata ca aceste suplimente ar putea inrautati rezistenta la insulina. Si condroitinul poate cauza sangerare la oamenii ce consuma solventi de sange.

-Unii cercetatori sugereaza ca folosirea zilnica a 12 grame de cartilaj de rechin in doze divizate, reducand-o pana la 3 grame zilnic, aduce de asemenea imbunatatiri.

-In prezent auzim tot mai multe despre importanta unei diete sanatoase. Este o terapie puternica pentru orice boala, si artrita nu face exceptie.

-Studiile arata ca o dieta puternic vegetariana are un puternic efect anti-inflamator, care ar putea reduce durerea articulatiilor.

-Pacientii cu artrita ar trebui sa se concentreze pe carbohidratii complexi precum grane, legume, vegetale si fructe intregi. Aceste alimente contin de asemenea vitamine bogate in antioxidanti, minerale si compusi numiti fitochimicale care ofera multe beneficii.

-Acizii grasi omega-3 sunt numerosi in acidul eicosapentenoic (EPA) si sunt prezenti in uleiurile de peste. Ei pot ajuta la usurarea durerii artritei prin reducerea productiei de prostaglandine care cauzeaza durerea si inflamarea. Uleiul din samanta de in este o sursa buna pentru acizii grasi esentiali. Sau puteti lua doua capsule de 360 mg de EPA de doua ori pe zi in timpul meselor.

-Un raport al Clinicii Mayo sustine ca S-adenosil metionina (SAM-e), un supliment nutritiv, a aratat ca poate reduce durerea si ca un amestec ayurvedic de ghimbir, turmenic, tamaie si ashwaganandia ar putea oferi o reducere considerabila a durerii

-Dr. Gifford-Jones este un jurnalist medical si practica in Toronto

-La lista de mai sus am mai adauga; Curcumin (Curcuma longa=turmeric), Noni (Morinda citrifolia), Bromelaina, Enzimele proteolitice, Serapeptaza (super enzima proteolitica) sau produsul anti-inflamator INFLAMO.

-Pentru cazuri cronice, produsele pe baza de Serapeptaza pot face adevarate minuni. Astfel de produse sunt: INFLA HEAL-Plus, SERRAPLEX, SERAPEPTAZA

-Punem la dispozitie in aceasta farmacie toate aceste produse sau formulatii


-DESPRE SAMe:
--SAMe IsoActive 200 mg (400 mg SAMe)/30 tab. enterice. Depresie, Osteoartrita, Ciroza

-SAM-e ISOActive 200 mg

-(Echivalentul a 400+ mg SAMe)

-30 tablete acoperite enteric

-OSTEOARTRITA
-BOLI DE FICAT (CIROZA)
-DEPRESIE
-PRURITA,
-ALZEIMER
-FIBROMIALGIE

-Introdus relativ recent pe piata, SAMe (S-Adenosil-L-Mationina bisulfat tosilat) a reprezentat o adevarata revolutie in tratarea depresiei nervoase si a osteoartritei.

-SAMe de la Nature’s Harmony denumit SAMe ISOActive este extras printr-un proces natural din S-Adenosil-L-Metionina bisulfat tosilat si are o actiune biologica cel putin dubla fata de SAMe obisnuit.

-SAMe este un agent biologic important pentru organismul uman, participand la peste 40 de reactii bio-chimice importante

-SAMe participa la reactiile de detoxificare si la reactiile de producere a substantelor chimice din creier, a antioxidantilor, a structurii articulatiilor ca si a multor alte componente importante

-SAMe creste nivelul de dopamina, un neurotransmitator important in reglarea starilor nervoase.

-Numerose studii clinice au indicat efectele excelentele ale Adenosilmetioninei (SAMe) in tratarea starilor de Depresie Nervoasa, a Pruritei si a Osteoartritei

-Se remarca prin efecte resimtite foarte rapid, in majoritatea cazurilor dupa 7 zile de tratament cu 400mg/zi

-SAMe s-a dovedit eficient in tratamentul cirozei hepatice avansate, in special cea cauzata de alcolism, reducand rata deceselor cu 47% dupa un tratament de 2 ani.


-ADMINISTRARE:
-1) -Depresie, osteoartrita: 2 tablete (400 mg) pe zi
-Tratament minim recomandat: 7 zile
-Tratament optim recomandat: 15 zile

-2) -Afectiuni hepatice: 2-8 tablete/zi

-3) Osteoartrita acuta: 2-8 tablete pe zi, minimum 7 zile


-COMPOZITIE:
-SAMe IsoActive ………...................................…………….200 mg/Tableta
(Concentrat obtinut din 385 mg de SAMe - S-Adenosil-L-Metionina bisulfat tosilat)


-REFERINTE
tudii vs. Placebo
-Cerutti R, Sichel MP, Perin M, et al. Psychological distress during puerperium: a novel therapeutic approach using S-adenosylmethionine. Curr Ther Res. 1993;53:707-16.
-Fava M, Rosenbaum JF, MacLaughlin R, et al. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990;24:177-184.
-Kagan BL, Sultzer DL, Rosenlicht N, Gerner RH. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 1990;147:591-595.
-Salmaggi P, Bressa GM, Nicchia G, et al. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women. Psychother Psychosom. 1993;59:34-40.

-Studii comparative (anti-depresivi):
-De Vanna M, Rigamonti R. Oral S-adenosyl-L-methionine in depression. Curr Ther Res. 1992;52:478-485.
-Potkin SG, Bell K, Plon L, Bunney WE Jr. Rapid antidepressant response with SAMe. A double-blind study. Ala J Med Sci. 1988;25:313-316.
-Taylor KM, Randall PK. Depletion of S-adenosyl-L-methionine in mouse brain by antidepressive drugs. J Pharmacol Exp Ther. 1975;194:303-310.
-Berlanga C, Ortega-Soto HA, Ontiveros M, Senties H. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine. Psychiatry Res. 1992;44:257-262.

-FICAT:
-Chawla RK, Bonkovsky HL, Galambos JT. Biochemistry and pharmacology of s-adenosyl-L-methionine and rationale for its use in liver disease. Drugs. 1990;40(Suppl 3):98-110.
-Friedel HA, Goa KL, Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs. 1989;38:389-416.
-Lieber CS. Role of S-adenosyl-L-methionine in the treatment of liver diseases. J He patol. 1999;30:1155-1159.
-Osman E, Owen JS, Burroughs AK. Review article: S-adenosyl-L-methionine-a new therapeutic agent in liver disease? Aliment Pharmacol Ther. 1993;7:21-28.

-Teste Clinice:
-Colell A, Garcia-Ruiz C, Morales A, et al. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine. Hepatology. 1997;26:699-708.
-Duce AM, Ortiz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology. 1988;8:65-68.
-Frezza M, Pozzato G, Chiesa L, Stramentinoli G, di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose s-adenosyl-L-methionine administration. Hepatol. 1984;4:274-278.
-Frezza M, Tritapepe R, Pozzato G, Di Padova C. Prevention by S-adenosylmethionine of estrogen-induced hepatobiliary toxicity in susceptible women. Am J Gastroenterol. 1988;83:1098-1102.
-Frezza M, Centini G, Cammareri G, Le Grazie C, di Padova C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepato-gastroenterology. 1990;37(suppl 2):122-125.
-Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology. 1990;99:211-215.
-Loguercio C, Nardi G, Argenzio F, et al. Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease. Alcohol.
1994;29:597-604.
-Mato JM, Camara J, Fernandez de Paz JF, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 1999;30:1081-1089.
-Milkiewicz P, Mills CO, Roma MG, et al. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestatis: a study in isolated rat hepatocyte couplets. Hepatology. 1999;29:471-476.
-Vendemiale G, Altomare E, Trizio T, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 1989;24:407-415.

-ARTICULATII:
-Di Padova C. S-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studies. Am J Med. 1987;83(5A):60-65.
-Schumacher HR Jr. Osteoarthritis: the clinical picture, pathogenesis, and management with studies on a new therapeutic agent, S-adenosylmethionine. Am J Med. 1987;83(5A):1-4.

-Teste Clinice:
-Barcelo HA, Wiemeyer JC, Sagasta CL, Macias M, Barreira JC. Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits. Am J Med. 1987;83(5A):55-59.
-Berger R, Nowak H. A new medical approach to the treatment of osteoarthritis. Report of an open phase IV study with ademetionine (Gumbaral). Am J Med. 1987;83(SA):84-88.
-Bradley JD, Flusser D, Katz BP, et al. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J Rheumatol. 1994;21:905-911.
-Brandt KD. Ef fects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med. 1987;83(5A);29-34.
-Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. Am J Med. 1987;83(5A):66-71.
-Glorioso S, Todesco S, Mazzi A, et al. Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis. Int J Clin Pharmacol Res. 1985;5:39-49.
-Harmand MF, Vilamitjana J, Maloche E, Duphil R, Ducassou D. Effects of S-adenosylmethionine on human articular chondrocyte differentiation. Am J Med. 1987;83(5A):48-54.
-Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med. 1987;83(5A):89-94.
-Konig H, Stahl H, Sieper J, Wolf KJ. Magnetic resonance tomography of finger polyarthritis: morphology and cartilage signals after ademetionine therapy. [Article in German] Aktuelle Radiol. 1995;5:36-40.
-Laudanno OM. Cytoprotective effect of S-adenosylmethionine compared with that of misoprostol against ethanol-, aspirin-, and stress-induced gastric damage. Am J Med. 1987;83(5A):43-47.
-Maccagno A, Di Giorgio EE, Caston OL, Sagasta CL. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med. 1987;83(5A):72-77.
-Marcolongo R, Giordano N, Colombo B, et al. Double-blind multicentre study of the activity of s-adenosyl-l-methionine in hip and knee osteoarthritis. Curr Ther Res. 1985;37:82-94.
-Muller-Fassbender H. Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. Am J Med. 1987;83(5A):81-83.
-Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med. 1987;83(5A):78-80.
-Zhang M, Borovikova LV, Wang H, Metz C, Tracey KJ. Spermine inhibition of monocyte activation and inflammation. Mol Med. 1999;5:595-605.

-ALTE AFECTIUNI:
-Parkinson:
-Carrieri PB, Indaco A, Gentile S, et al. S-Adenosylmethionine treatment of depression in patients with Parkinson's disease: a double-blind crossover study versus placebo. Curr Ther Res. 1990;48:154-160.
-Cheng H, Gomes-Trolin C, Aquilonius SM, et al. Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol. 1997;145:580-585.


-Neurologie:
-Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs. 1994;48:137-152.
-Bottiglieri T. Ademetionine (S-adenosylmethionine) neuropharmacology: Implications for drug therapies in psychiatric and neurological disorders. Exp Opin Invest Drugs. 1997;6:417-426.
-Pavia J, Martos F, Gonzalez-Correa JA, et al. Effect of S-adenosyl methionine on muscarinic receptors in young rats. Life Sci. 1997;60:825-832.
-Takahashi J, Nishino H, Ono T. S-adenosyl-L-methionine facilitates recovery from deficits in delayed response and hand movement tasks following brain lesions in monkeys. Exp Neurol. 1987;98:459-471.


-Alzheimer/ Imbatranire:
-Cimino M, Vantini G, Algeri S, et al. Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. Life Sci. 1984;34:2029-2039.
-Fontanari D, Di Palma C, Giorgetti G, et al. Effects of S-adenosyl-L-methionine on cognitive and vigilance functions in the elderly. Curr Ther Res. 1994;55:682-689.
-Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem. 1996;67:1328-1331.
-Stramentinoli G, Gualano M, Catto E, Algeri S. Tissue levels of S-adenosylmethionine in aging rats. J Gerontol. 1977;32:392-394.

-DR.MARK STENGLER REF.SAME:"IN CEL MAI AMPLU
STUDIU LEGAT DE SAME SI DE ARTROZA,CERCETATORII AU
URMARIT EVOLUTIA UNUI NUMAR DE 20641 DE PERSOANE CARE
AU LUAT SAME TIMP DE 8 SAPTAMANI.PACIENTII AU LUAT
400MGX3/ZI IN PRIMA SAPTAMANA,400MGX2/ZI IN ADOUA
SAPTAMANA SI 200MGX2/ZI DIN A TREIA PANA IN A OPTA
SAPTAMANA.71% DINTRE CEI CARE AU FOLOSIT SAME AU
RAPORTAT REZULTATE BUNE SI FOARTE BUNE,IN TIMP CE
NUMAI 9% AU RAPORTAT REZULTATE SLABE...ALATURI DE UN
REGIM ALIMENTAR BUN SI DE MISCARE,SAME ESTE UN
TRATAMENT DE BAZA PENTRU SCADEREA SIMPTOMELOR DE
ARTROZA SI PENTRU REGENERAREA CARTILALULUI."

-ACEST PRODUS IL GASITI LA NOI IN FARMACIE !!!

Nota: Preturile afisate contin TVA. Fotografia prezentata are caracter informativ si pot exista diferente intre aceasta si produsul respectiv. Specificatiile pentru produsul ARTRITA, TRATEAZ O PE CALE NATURALA !!! au caracter informativ, pot fi schimbate fara instiintare prealabila si nu constituie obligativitate contractuala. Pret ARTRITA, TRATEAZ O PE CALE NATURALA !!! poate fi schimbat fara notificare prealabila. Va rugam inainte sa comandati un produs sa cititi Termeni si conditii.
Top
Timp generare pagina: 0.6659 sec.
sc Medical Active srl, CIF: RO16463753, Reg.Com.: J09/441/27.05.2004 - 8
Copyright © 2007-2010
realizat de webdesignagency.ro
site valid XHTML 1.0 Transitional
site valid CSS 2.1